Related Experiment Video
Updated: May 8, 2026

Toxicity Screens in Human Retinal Organoids for Pharmaceutical Discovery
Published on: March 4, 2021
Advances and applications of organoid-on-a-chip in disease modeling
Yujia Yang1,2,3,4, Jinhui Sheng5, Fengqiu Sheng6
1Epigenetics in Human Health and Disease Program, Baker Heart and Diabetes Institute, 75 Commercial Road, Melbourne, 3004, VIC, Australia.
Abstract:
Recent studies have emphasized the ability of organoids, a class of self-organizing mini-organs derived from various cell sources and tissue biopsies, to faithfully replicate the main anatomical features and physiological traits of internal organs. Because of the numerous avenues this technology has opened for biomedical research, there is a growing need for creative engineering approaches to create, manufacture, manipulate, and study organoids and their microenvironments. This review covers the most recent developments in disease modeling for both the organoid-on-a-chip and the more recent, more sophisticated multiorgan-on-a-chip platforms. These technologies have the potential to significantly influence a few growing biomedical domains, including disease modeling, drug discovery, toxicity and drug screening, and personalized precision medicine. We also discuss the upcoming prospects and difficulties for the advancement and use of organoid-on-a-chip technology.
Related Concept Videos
Mouse Models of Cancer Study
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
iChip

